TB-500 – Peptide for Regeneration and Tissue Healing
TB-500 is a synthetic peptide derived from the naturally occurring protein Thymosin Beta-4, studied for its potential to support tissue healing, regeneration, and anti-inflammatory effects.
Things worth knowing about "TB-500"
TB-500 is a synthetic peptide derived from the naturally occurring protein Thymosin Beta-4, studied for its potential to support tissue healing, regeneration, and anti-inflammatory effects.
What is TB-500?
TB-500 is a synthetic peptide derived from Thymosin Beta-4 (TB4), a protein that occurs naturally in virtually all human cells. It represents a shorter, biologically active fragment of the full Thymosin Beta-4 molecule, designed to replicate its key regenerative and anti-inflammatory properties. Thymosin Beta-4 plays a fundamental role in cell migration, tissue repair, and the regulation of inflammatory responses throughout the body.
TB-500 is primarily discussed in the context of sports science, regenerative medicine, and veterinary medicine. It is not approved as a pharmaceutical drug for human use but is actively studied in research settings worldwide.
Mechanism of Action
The primary mechanism of TB-500 involves its ability to bind to actin, a structural protein essential for cell movement and growth. Through this interaction, TB-500 promotes several key biological processes:
- Cell migration: TB-500 stimulates the movement of cells toward injured tissue, accelerating the wound-healing process.
- Angiogenesis: It promotes the formation of new blood vessels, improving oxygen and nutrient delivery to damaged areas.
- Anti-inflammatory effects: TB-500 helps modulate inflammatory responses, reducing excessive or chronic inflammation.
- Tissue regeneration: It supports the repair of muscle, tendon, ligament, and cartilage tissue.
Areas of Application
Recovery from Injuries
TB-500 is primarily discussed as a means of accelerating recovery from muscle, tendon, and ligament injuries. In veterinary medicine, particularly in racehorses, TB-500 has been used to support athletic recovery and performance.
Inflammatory Conditions
Due to its anti-inflammatory properties, TB-500 is also being investigated in preclinical studies for chronic inflammatory and autoimmune conditions.
Cardiac Muscle Regeneration
Research suggests that Thymosin Beta-4 and its derivatives, including TB-500, may have protective effects on cardiac muscle cells and could support regenerative processes following a heart attack.
Administration and Dosage
TB-500 is typically administered via subcutaneous injection. Since it is not an approved pharmaceutical for human use, there are no officially established dosage guidelines. In preclinical studies and veterinary applications, doses in the microgram to milligram range have been used.
Important: The use of TB-500 in humans outside of controlled clinical trials is considered experimental and is not legally approved in many countries.
Side Effects and Safety
Since clinical human studies remain limited, the complete side effect profile of TB-500 is not yet fully established. Based on available preclinical data and anecdotal reports, the following risks have been identified:
- Local injection site reactions (redness, swelling)
- Potential promotion of tumor growth due to increased angiogenesis (theoretical risk)
- Interactions with other medications not yet fully characterized
- Quality and purity risks associated with unregulated sources
Legal Status and Anti-Doping
TB-500 is listed on the World Anti-Doping Agency (WADA) Prohibited List and is banned for use by competitive athletes. It is classified as a peptide hormone and growth factor, placing it firmly within the category of prohibited substances in sport. Athletes must familiarize themselves with the legal regulations in their country and the applicable anti-doping rules before considering any use.
Current State of Research
Numerous preclinical animal studies have demonstrated promising results regarding the regenerative properties of TB-500. However, clinical trials in humans remain scarce, and the scientific evidence supporting its therapeutic use in humans is currently limited. Ongoing research is focusing on cardiac disease, wound healing, and neurodegenerative conditions as primary areas of interest.
References
- Goldstein AL, Kleinman HK. - Advances in the basic and clinical applications of thymosin beta-4. - Expert Opinion on Biological Therapy, 2011.
- Philp D, Kleinman HK. - Animal studies with thymosin beta-4, a multifunctional tissue repair and regeneration peptide. - Annals of the New York Academy of Sciences, 2010.
- World Anti-Doping Agency (WADA) - Prohibited List 2024. - www.wada-ama.org
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categorySelf-acceptance
Meniscal lesion
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: TB-500-en